ITRM vs ROL · rev $390.0K vs P/E 41, rev $3.39B
Iterum Therapeutics PLC (ITRM) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
ITRM currently screens at market cap $38.6M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the ITRM and ROL stock pages for the full models.
Not investment advice.